From: Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
Response
No of Patient
%
CR
25
6.2
PR
120
29.9
SD
140
34.8
PD
103
25.6
ORR (CR + PR)
145
36.1
DCR (CR + PR + SD)
285
70.9
NE
14
3.5
Total
402
100.0